- Home
- NFBK vs ANGO Comparison
NFBK vs ANGO Comparison
Compare NFBK & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NFBK
- ANGO
- Stock Information
- Founded
- NFBK 1887
- ANGO 1988
- Country
- NFBK United States
- ANGO United States
- Employees
- NFBK N/A
- ANGO N/A
- Industry
- NFBK Major Banks
- ANGO Medical/Dental Instruments
- Sector
- NFBK Finance
- ANGO Health Care
- Exchange
- NFBK Nasdaq
- ANGO Nasdaq
- Market Cap
- NFBK 454.5M
- ANGO 400.8M
- IPO Year
- NFBK 2007
- ANGO 2004
- Fundamental
- Price
- NFBK $10.00
- ANGO $11.73
- Analyst Decision
- NFBK Hold
- ANGO Strong Buy
- Analyst Count
- NFBK 3
- ANGO 3
- Target Price
- NFBK $12.67
- ANGO $19.33
- AVG Volume (30 Days)
- NFBK 192.0K
- ANGO 442.6K
- Earning Date
- NFBK 10-22-2025
- ANGO 10-02-2025
- Dividend Yield
- NFBK 5.08%
- ANGO N/A
- EPS Growth
- NFBK 51.92
- ANGO N/A
- EPS
- NFBK 0.97
- ANGO N/A
- Revenue
- NFBK $141,983,000.00
- ANGO $300,718,000.00
- Revenue This Year
- NFBK $9.42
- ANGO $8.18
- Revenue Next Year
- NFBK $7.14
- ANGO $5.15
- P/E Ratio
- NFBK $10.53
- ANGO N/A
- Revenue Growth
- NFBK 13.99
- ANGO 2.73
- 52 Week Low
- NFBK $9.40
- ANGO $6.63
- 52 Week High
- NFBK $14.39
- ANGO $13.50
- Technical
- Relative Strength Index (RSI)
- NFBK 32.36
- ANGO 51.11
- Support Level
- NFBK $10.00
- ANGO $11.46
- Resistance Level
- NFBK $10.25
- ANGO $12.18
- Average True Range (ATR)
- NFBK 0.29
- ANGO 0.36
- MACD
- NFBK -0.05
- ANGO -0.08
- Stochastic Oscillator
- NFBK 1.97
- ANGO 22.66
About NFBK Northfield Bancorp Inc. (Delaware)
Northfield Bancorp Inc is the holding company for Northfield Bank. Its subsidiary provides banking services to individuals and corporate customers in Richmond and Kings Counties in New York, and Hunterdon, Mercer, Union and Middlesex counties in New Jersey. The bank attracts deposits and offers credit and other banking services.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.